Through an integral
treatment approach to therapy, utilizing treatments grounded in Cognitive Behavioral (CBT), psychoanalysis and interpersonal principles, I strive to create a safe atmosphere, fostering trust within the therapeutic relationship.
Not exact matches
«Today's approval marks another first in the field of gene
therapy — both in how the
therapy works and in expanding the use of gene
therapy beyond the
treatment of cancer
to the
treatment of vision loss — and this milestone reinforces the potential of this breakthrough
approach in treating a wide - range of challenging diseases,» FDA Commissioner Scott Gottlieb said in a statement.
Katherine High, Spark's president and chief scientific officer, expressed her enthusiasm for the early clinical data related
to SPK - 8011: «The encouraging start of our SPK - 8011 clinical trial reinforces the strength of our gene
therapy platform, delivers human proof - of - concept in a second liver - mediated disease — a significant achievement in the gene
therapy field — and positions us well
to potentially transform the current
treatment approach for this life - altering disease with a one - time intervention.»
Like the Antabuse
treatment, this
approach is adjunctive
to other
therapies; most programs using it couple it with group or individual psychotherapy.
Dr. Laptook specializes is Cognitive - Behavioral
Therapy and Parent Training and uses these
approaches in the
treatment of Selective Mutism, with interventions focusing on gradual exposures
to facilitate verbalization in the context of working together with both the family and the school setting.
Describes the characteristics and benefits of parent - child interaction
therapy (PCIT), a family - centered
treatment approach proven effective for abused and at - risk children ages 2
to 8 and their caregivers — birth parents, adoptive parents, or foster or kin caregivers.
In addition, TF - CBT appears
to be more effective than other types of
treatment approaches that may be used with children with a history of sexual abuse, such as supportive
therapy or play
therapy.
We exist
to advance play
therapy, the
treatment approach in which licensed professionals use the natural benefits of play
to improve the mental health of children, families, and adults!
Head orthesis
therapy in infants with unilateral positional plagiocephaly: an interdisciplinary
approach to broadening the range of orthodontic
treatment.
Several studies have shown the benefit of craniosacral
therapy as a
treatment approach to correct disorganized and dysfunctional sucking.
The types of
treatment options include medication
to help with some symptoms, behavior and education
therapy, parent training, and other alternative
approaches.
The Association for Behavioral and Cognitive
Therapies is a multidisciplinary organization committed
to the advancement of scientific
approaches to the understanding and improvement of human functioning through the investigation and application of behavioral, cognitive and other evidence - based principles
to the assessment, prevention,
treatment of human problems and the enhancement of health and well - being.
People with chronic opioid use disorders are more likely
to relapse and do so sooner if they are treated in a compulsory drug detention centre rather than a voluntary drug
treatment centre using methadone maintenance
therapy, according
to the first study comparing the outcome of both
approaches published in The Lancet Global Health.
Strikingly, the
treatment approach didn't make a difference
to 10 - year survival: Ninety - nine percent of the more than 1600 men in the trial were alive after a decade, whether they had initially received radical surgery, radiation, or active monitoring, which meant no immediate
therapy, but intervention as needed.
Breast cancer patients may be at an increased risk of cardiovascular diseases including heart failure and may benefit from a
treatment approach that weighs the benefits of specific
therapies against potential damage
to the heart, according
to a new scientific statement from the American Heart Association published in its journal Circulation.
Treatments aimed at revving up the immune system's attack on the cancer may be the most promising
approach to cancer
therapy since combination chemotherapy.
Luznik says that the researchers» next step will be
to test the short course
therapy in a phase III randomized clinical trial that would directly compare results in patients who receive the cyclophosphamide
treatment with those who receive either a separate, experimental
approach to prevent GVHD or the more traditional six - month immunosuppressive
therapy.
Now a paper in the November 2009 issue of Science suggests that the long - sought cure may come from gene
therapy — a famously hyped
approach to treatment that tragically caused the death of a teenage experimental subject in 1999.
In this
approach, a patient's individual risk of suffering heart disease due
to breast cancer
treatment will be taken into account already when choosing the adequate
therapy.
«We are hoping
to help improve current mental health
treatments by first predicting who is most at - risk so that we can intervene earlier, and second, by using these types of
approaches to determine who might benefit from a given
therapy,» Scult said.
Such a
treatment might be combined with a gene
therapy approach, also being pursued by her team and other groups, delivered directly
to the brain
to curtail mHTT expression.
Women with a DCIS diagnosis who participate in the study will be randomized
to receive one of two
treatment approaches: The current standard of care consisting of surgery and radiation
therapy, or careful monitoring with mammograms and physical exams every six months.
Research on metastatic colorectal cancer and sarcoma, however, suggests a potential benefit from adding local
therapy —
treatment directed specifically at the tumor cells —
to the standard
approach of systemic
therapy.
Clauw advises clinicians
to integrate pharmacological
treatments, such as gabapentinoids, trycyclics and serotonoin reuptake inhibitors, with nonpharmacological
approaches like cognitive behavioral
therapy, exercise and stress reduction.
However, if there is no approved
treatment for an ailment, the FDA has a compassionate
therapy exception that allows the patient
to agree
to try an experimental
approach.
Such an
approach is likely
to work best when performed in combination with other
treatment strategies, such as antiretroviral
therapy.
To help find simpler, safer
treatment options, researchers at National Jewish Health evaluated an
approach known as wet wrap
therapy.
Dr. Cooper joined MDACC in 2006 as section chief of cell
therapy at the Children's Cancer Hospital, where he cared for children undergoing bone marrow transplantation and led scientific efforts
to develop new
treatment approaches that pair genetic engineering with immunotherapies.
«Today's approval marks another first in the field of gene
therapy — both in how the
therapy works and in expanding the use of gene
therapy beyond the
treatment of cancer
to the
treatment of vision loss — and this milestone reinforces the potential of this breakthrough
approach in treating a wide - range of challenging diseases,» FDA Commissioner Scott Gottlieb said in a statement.
Kohn's gene
therapy approach using HSC from patient's own blood is a revolutionary alternative
to current SCD
treatments as it creates a self - renewing normal blood cell by inserting a gene that has anti-sickling properties into HSC.
«At Exeter we are already developing specific psychological
therapies, running clinical trials of novel drug
approaches and using - cutting edge genetic techniques
to identify new targets for safe and effective
therapies and
to allow us
to use current
treatments in a more focussed way.»
Down the road, gene
therapy and other
approaches look likely
to bring longer - term
treatments for patients with the rare bleeding disorder.
The data were considered using meta - analysis, an
approach long used in fields such as biomedicine
to determine the effectiveness of a
treatment based on studies with a variety of patient groups, providers and ways of administering the
therapy or drugs.
Unlike conventional chemotherapies, this new
approach to cancer
therapy has fewer toxic side effects, and gives hope for a cancer
treatment that is gentler on young bodies.
This visual abstract depicts how Wei et al. utilize single - cell phosphoproteomic analysis of patient derived glioblastoma models
to identify shifts in signaling coordination following short - term
treatment with kinase inhibitors, which facilitates the design of combination
therapy approaches with reduced resistance and improved efficacy.
Compared
to the conventional radiation
therapy (RT)
approach of small doses given daily over several weeks, SBRT delivers a highly targeted, escalated dose of radiation in a single session or as many as five of
treatments, usually between one and five fractions.
«Until now, the main
approach to develop
treatments for anaemia of chronic disease was
to look for anti-hepcidin
therapies,» says Hentze.
PTSD
treatment includes trauma - focused
therapy, which includes Written Exposure Therapy (WET), a five - session psychotherapy program, or Cognitive Processing Therapy (CPT), a 12 - session psychotherapy program that is considered to be a first - line PTSD treatment ap
therapy, which includes Written Exposure
Therapy (WET), a five - session psychotherapy program, or Cognitive Processing Therapy (CPT), a 12 - session psychotherapy program that is considered to be a first - line PTSD treatment ap
Therapy (WET), a five - session psychotherapy program, or Cognitive Processing
Therapy (CPT), a 12 - session psychotherapy program that is considered to be a first - line PTSD treatment ap
Therapy (CPT), a 12 - session psychotherapy program that is considered
to be a first - line PTSD
treatment approach.
«RNAi
therapies are a unique
approach to cancer
treatment as they have the potential
to «turn off» the genes» coding for proteins involved in cancer cell division,» said Ramesh K. Ramanathan, M.D., medical director of the Virginia G. Piper Cancer Center Clinical Trials Program at Scottsdale Healthcare and deputy director of the Clinical Translational Research Division of the Translational Genomics Research Institute (TGen) in Phoenix, Ariz. «Using a lipid nanoparticle, the RNAi drug can be delivered
to a cancer cell
to block the expression of specific proteins involved in tumor growth.»
This conclusion is biologically plausible because androgen suppression
therapy is a standard
approach to the
treatment of primary prostate cancer, and recurrence invariably is associated with a loss of growth ‐ dependence on androgens.
«Analysis of metastatic prostate cancers suggests
treatment options: Study maps out abnormal signaling pathways in prostate cancer cells and provides computational
approaches to identify individualized targets for
therapy.»
This
approach aims
to push the boundaries of discovery by promoting the translation of basic research discoveries into
therapies and
treatment.
At a time when gene
therapy has been revived as a potent form of cancer
treatment, a new
approach would use nanoparticles, rather than viruses,
to deliver strands of DNA or RNA
to tumors.
Concepts of how
to apply vaccines as part of cancer
treatment or as prevention of recurrence, are moving vaccines from being considered a secondary player in cancer clinical management
to vaccine
approaches gravitating towards becoming a central plank in the newest area of cancer
therapy research.
His key investments in regenerative medicine technologies have laid the groundwork for novel
approaches to treatments aimed at generating not merely palliative but actual curative and restorative
therapies.
Through the clinical training sessions, Bohus, currently a visiting professor at McLean, provided guidance on his modification of dialectical behavior
therapy (DBT) for BPD and complex PTSD
to McLean clinicians, marking the first time he has taught his innovative evidence - based
treatment approach in the US.
Bosarge is known for his transformative
approaches to regenerative medicine in cancer research that utilize targeted
therapies and personalized
treatment paths.
Using agent - based modelling and simulation
approaches, we contribute
to a better understanding of disease development and / or
treatment effects (e.g. the context of leukaemia
treatment or gene
therapy approaches).
The work being done by scientists at Longevica may lead
to a novel
approach in cancer
therapy that can significantly improve the efficiency of the current methods of cancer
treatment.
«In particular, his
approach can be thought of as a very advanced biological
therapy for the
treatment of breast cancer; one that uses viruses, which are better recognized
to cause disease,
to treat human breast cancers.»